Post by Mölnlycke Health Care

We’re strengthening our global manufacturing footprint to power the future of wound care. Today we confirmed a EUR 40 million investment in our Mikkeli, Finland and Oldham, UK facilities to increase capacity and supply chain resilience, optimise process quality and drive more sustainable manufacturing. The investment's projected impact will include: • +50% capacity increase in Mikkeli • Faster lead times in Oldham • A more connected, future-ready network Along with the recent expansion activities in Brunswick, USA, and Changshu, China, these coordinated investments reflect Mölnlycke’s continued focus on meeting growing demand for advanced wound care solutions and helping to free patients from the burden of wounds. Read the press release in the comments section below.